Am J Transplant, Volume 19, Suppl 3 Archives - Page 95 of 214 - ATC Abstracts

2019 American Transplant Congress
Decreased Cancer Susceptibility in Tolerant Liver Transplant Recipients: Another Benefit of Tolerance?
M. P. Bhat¹, E. Pasini¹, C. Baciu¹, S. M. Kurian², J. Levitsky³
¹Multi-Organ Transplant, UHN, Toronto, ON, Canada, ²Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, ³Division of Gastroenterology & Hepatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
*Purpose: Long-term survival of transplant recipients is significantly impacted by malignancy. Induction of tolerance is feasible in a subset of liver transplant (LT) recipients. The…
2019 American Transplant Congress
The Effects of Anti-BAFF Monoclonal Antibody in the HLA-A2 Sensitized Mouse Model
J. Min¹, H. Lee², B. Kim³, K. Park⁴, K. Doh³, T. Kim⁵, H. Yoon⁶, C. Yang⁷, E. Oh², B. Chung⁷
¹Division of Nephrology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon-si, Korea, Republic of, ²Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of, ³Convergent Research Consortium for Immunologic Disease, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of, ⁴Department of Molecular & Cell Biology, Graduate School, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of, ⁵Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of, ⁶Division of Nephrology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea, Republic of, ⁷Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of
*Purpose: B-cell activating factor (BAFF) is a cytokine that plays a role in the survival, proliferation and differentiation of B-cells. The aim of this study…
2019 American Transplant Congress
Use of Latent Class Analysis to Identify Patient Symptom Burden Subgroups after Living Donor Kidney Transplant
J. Peipert, J. Caicedo-Ramirez, K. Ensor, J. Friedewald, M. Abecassis, D. Cella, D. Ladner, Z. Butt
Northwestern University, Chicago, IL
*Purpose: Identifying groups of patients based on clusters of symptoms they experience may help advance our understanding of living donor kidney transplant (LDKT) recipients’ post-operative…
2019 American Transplant Congress
Impact of Simultaneous Pancreas-Kidney Transplantation on Cardiovascular Risk in Type 1 Diabetic Patients
E. Montagud-Marrahi
Servei de Nefrologia i Trasplantament Renal, Hospital Clínic de Barcelona, Barcelona, Spain
*Purpose: Cardiovascular disease is the main cause of death in patients with type 1 diabetes mellitus (DM1). Information available about the impact of simultaneous pancreas-kidney…
2019 American Transplant Congress
Dialysis Facility Profit Status and Referral for Kidney Transplantation
E. R. Walker¹, L. J. McPherson¹, J. C. Gander², S. Pastan¹, R. E. Patzer¹
¹Emory University School of Medicine, Atlanta, GA, ²Kaiser Permanente Georgia, Atlanta, GA
*Purpose: Patients receiving dialysis treatment in for-profit dialysis facilities have historically lower rates of kidney transplantation (KT) compared to non-profit facilities, but the impact of…
2019 American Transplant Congress
The Impact of Extra-Anatomical Hepatic Artery Reconstruction during Living Donor Transplantation on Biliary Complications and Graft and Patient Survival
Y. Chung, J. Kim, S. Kim, J. Rhu, S. Lee, K. Lee, S. Lee, G. Choi, J. Park, S. Kim, J. Joh, S. Lee
Transplantation, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: This study was designed to analyze the feasibility of extra-anatomical hepatic artery reconstruction in living donor liver transplantation.*Methods: Patients who underwent their first living…
2019 American Transplant Congress
Tolerogenic Nanoparticles Targeting the Aryl Hydrocarbon Receptor
K. Janek¹, J. Fechner¹, S. Gong², Y. Wang², J. Mezrich¹
¹Department of Surgery, Division of Transplantation, University of Wisconsin Hospital and Clinics, Madison, WI, ²Department of Biomedical Engineering, University of Wisconsin Madison, Madison, WI
*Purpose: The aryl hydrocarbon receptor (AHR) has been shown to have a central role in the ability of dendritic cells (DCs) to direct differentiation of…
2019 American Transplant Congress
Impact Of Selective Cd28 Blockade On Protective Immunity To A Murine Epstein-Barr Virus Homolog
R. L. Crepeau, J. A. Elengickal, M. L. Ford
Surgery, Emory University, ATLANTA, GA
*Purpose: CTLA-4Ig blocks CD80/CD86, the ligands for both CD28 and CTLA-4. Thus, in addition to the intended effect of blocking CD28-mediated costimulation, CTLA4-Ig also has…
2019 American Transplant Congress
Defatting Steatotic Rat Livers during Ex Situ Normothermic Perfusion Improves Lactate Clearance and Bile Quality
S. Raigani¹, C. Carroll², S. Cronin², C. Pendexter², I. Rosales³, M. Yarmush¹, K. Uygun¹, H. Yeh¹
¹Transplant Surgery, Massachusetts General Hospital, Boston, MA, ²Center for Engineering in Medicine, Shriners Childrens Hospital, Boston, MA, ³Pathology, Massachusetts General Hospital, Boston, MA
*Purpose: Donor livers with moderate-to-severe steatosis are not generally used for transplantation because of poor post-transplant function. Ex situ normothermic machine perfusion (ENMP) provides an…
2019 American Transplant Congress
Effectiveness Of Percutaneous Embolization As Treatment Compared To Nephrectomy For Renal Graft Intolerance Syndrome In Late Graft Failure Patients
S. Kwon, J. Go, S. Park, S. Yoon, J. Kim, I. Moon
Department of Vascular and Transplant Surgery, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of
*Purpose: Failed renal allografts left in situ may cause inflammation presenting as graft intolerance syndrome (GIS). But there is no standardization for treatment of a…